| Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus PH Mygind, RL Fischer, KM Schnorr, MT Hansen, CP Sönksen, ... Nature 437 (7061), 975-980, 2005 | 597 | 2005 |
| Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases AG Jensen, CH Wachmann, F Espersen, J Scheibel, P Skinhøj, ... Archives of Internal Medicine 162 (1), 25-32, 2002 | 315 | 2002 |
| Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples H Hasman, D Saputra, T Sicheritz-Pontén, O Lund, CA Svendsen, ... Journal of clinical microbiology 52 (1), 139-146, 2014 | 300 | 2014 |
| Interplay in the selection of fluoroquinolone resistance and bacterial fitness LL Marcusson, N Frimodt-Møller, D Hughes PLoS pathog 5 (8), e1000541, 2009 | 286 | 2009 |
| Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance MB Kerrn, T Klemmensen, N Frimodt-Møller, F Espersen Journal of antimicrobial chemotherapy 50 (4), 513-516, 2002 | 240 | 2002 |
| In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers CH Lester, N Frimodt-Møller, TL Sørensen, DL Monnet, AM Hammerum Antimicrobial agents and chemotherapy 50 (2), 596-599, 2006 | 224 | 2006 |
| Presence of erm gene classes in Gram-positive bacteria of animal and human origin in Denmark LB Jensen, N Frimodt-Møller, FM Aarestrup FEMS Microbiology Letters 170 (1), 151-158, 1999 | 222 | 1999 |
| Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork TL Sørensen, M Blom, DL Monnet, N Frimodt-Møller, RL Poulsen, ... New England Journal of Medicine 345 (16), 1161-1166, 2001 | 207 | 2001 |
| Evaluation of a cefoxitin 30 µg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus R Skov, R Smyth, M Clausen, AR Larsen, N Frimodt-Møller, ... Journal of Antimicrobial Chemotherapy 52 (2), 204-207, 2003 | 198 | 2003 |
| Risk factors for hospital-acquired Staphylococcus aureus bacteremia AG Jensen, CH Wachmann, KB Poulsen, F Espersen, J Scheibel, ... Archives of internal medicine 159 (13), 1437-1444, 1999 | 194 | 1999 |
| Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark BL Røder, DA Wandall, N Frimodt-Møller, F Espersen, P Skinhøj, ... Archives of internal medicine 159 (5), 462-469, 1999 | 194 | 1999 |
| In vivo pathogenicity of eight medically relevant Candida species in an animal model M Arendrup, T Horn, N Frimodt-Møller Infection 30 (5), 286-291, 2002 | 178 | 2002 |
| Bacteremic Staphylococcus aureus spondylitis AG Jensen, F Espersen, P Skinhøj, N Frimodt-Møller Archives of internal medicine 158 (5), 509-517, 1998 | 178 | 1998 |
| Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990 AG Jensen, F Espersen, P Skinhøj, VT Rosdahl, N Frimodt-Møller Journal of Infection 34 (2), 113-118, 1997 | 178 | 1997 |
| Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T Benfield, F Espersen, N Frimodt-Møller, AG Jensen, AR Larsen, ... Clinical microbiology and infection 13 (3), 257-263, 2007 | 172 | 2007 |
| Clinical manifestations and molecular epidemiology ofVibrio vulnificus infections in Denmark A Dalsgaard, N Frimodt-Møller, B Bruun, L Høi, JL Larsen European Journal of Clinical Microbiology and Infectious Diseases 15 (3 …, 1996 | 171 | 1996 |
| Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies H Hvidberg, C Struve, KA Krogfelt, N Christensen, SN Rasmussen, ... Antimicrobial agents and chemotherapy 44 (1), 156-163, 2000 | 162 | 2000 |
| In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia DM Livermore, MW Carter, S Bagel, B Wiedemann, F Baquero, E Loza, ... Antimicrobial Agents and Chemotherapy 45 (6), 1860-1867, 2001 | 161 | 2001 |
| Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence MC Arendrup, E Mavridou, KL Mortensen, E Snelders, N Frimodt-Møller, ... PLoS One 5 (4), e10080, 2010 | 157 | 2010 |
| How predictive is PK/PD for antibacterial agents? N Frimodt-Møller International journal of antimicrobial agents 19 (4), 333-339, 2002 | 157 | 2002 |
